Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2021 | Pubmed ID: 33082214